日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Complement factor H supplementation rather than complete C3 knockout provides therapeutic benefits in IgA nephropathy

与完全敲除C3相比,补充补体因子H可为IgA肾病提供治疗益处。

Li, Xianzhi; Ni, Xinran; Yuan, Xiaohan; Wu, Huan; Shi, Sufang; Liu, Lijun; Lv, Jicheng; Zhang, Hong; Zhu, Li

Predictive Value of the Oxford Classification for the Effect of Glucocorticoid Therapy in IgA Nephropathy

牛津分类对糖皮质激素治疗IgA肾病疗效的预测价值

Shi, Sufang; Roberts, Ian S D; Wang, Zixuan; Jiang, Lei; Tang, Chen; Wang, Jinwei; Lv, Jicheng; Wong, Muh Geot; Barbour, Sean J; Perkovic, Vlado; Cattran, Daniel; Zhang, Hong

Dual Role of Factor H-Related Protein 1 in IgA Nephropathy Kidney Injury

因子H相关蛋白1在IgA肾病肾损伤中的双重作用

Kang, Yuqi; Li, Xianzhi; Yuan, Xiaohan; Shi, Sufang; Lv, Jicheng; Zhu, Li; Zhang, Hong

Lactobacillus casei Cell Wall Extract and Production of Galactose-Deficient IgA1 in a Humanized IGHA1 Mouse Model

干酪乳杆菌细胞壁提取物及在人源化IGHA1小鼠模型中产生半乳糖缺陷型IgA1

Li, Run; Wang, Manliu; Li, Jingyi; Zhu, Li; Xie, Xinfang; Wang, Hui; Zhang, Xu; Tian, Wenmin; Zhang, Yong; Dong, Yaping; Zan, Jincan; Li, Hongyu; Zhang, Yuemiao; Zhou, Xujie; Shi, Sufang; Shu, Chutian; Liu, Lijun; Jin, Jing; Lv, Jicheng; Zhang, Hong

Role of Systemic Glucocorticoids in Reducing IgA and Galactose-Deficient IgA1 Levels in IgA Nephropathy.

系统性糖皮质激素在降低 IgA 肾病中 IgA 和半乳糖缺乏型 IgA1 水平中的作用。

Zan Jincan, Li Jingyi, Wong Muh Geot, Kim Dana, Shi Sufang, Monaghan Helen, Perkovic Vlado, Lv Jicheng, Zhang Hong

Corticosteroid Effects in IgA Nephropathy by Baseline Proteinuria and Estimated GFR

根据基线蛋白尿和估算肾小球滤过率评估皮质类固醇对 IgA 肾病的影响

Kim, Dana; Neuen, Brendon L; Lv, Jicheng; Hladunewich, Michelle A; Jha, Vivekanand; Hooi, Lai Seong; Monaghan, Helen; Fletcher, Robert A; Billot, Laurent; Perkovic, Vlado; Zhang, Hong; Wong, Muh Geot

Sex Differences Across Corticosteroid Response and Outcomes in IgA Nephropathy

IgA肾病中皮质类固醇反应和预后的性别差异

Kim, Dana; Woodward, Mark; Lv, Jicheng; Hladunewich, Michelle A; Jha, Vivekanand; Hooi, Lai Seong; Monaghan, Helen; Perkovic, Vlado; Zhang, Hong; Wong, Muh Geot

Long-term evaluation of the timing of corticosteroid therapy in an IgA nephropathy cohort

对IgA肾病患者群体中皮质类固醇治疗时机的长期评估

Hou, Wanyin; Yang, Haiyan; Chen, Pei; Tang, Chen; Zhou, Xujie; Liu, Lijun; Zhu, Li; Shi, Sufang; Lv, Jicheng; Zhang, Hong

Novel therapies improve prognosis of IgAN and limit the applicability of the International IgA Nephropathy Prediction Tool

新型疗法改善了IgA肾病的预后,并限制了国际IgA肾病预测工具的适用性。

Shen, Xue; Chen, Pei; Liu, Lijun; Shi, Sufang; Zhou, Xujie; Barbour, Sean J; Lv, Jicheng; Zhang, Hong

Predictive value of Gd-IgA1, poly-IgA in the treatment of IgA nephropathy with targeted-release formulation budesonide.

Gd-IgA1、poly-IgA 在靶向释放制剂布地奈德治疗 IgA 肾病中的预测价值

Chen Qinlan, Chen Pei, He Rong, Zan Jincan, Shen Xue, Lv Jicheng, Zhang Hong